1. Home
  2. ASMB vs LGO Comparison

ASMB vs LGO Comparison

Compare ASMB & LGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASMB
  • LGO
  • Stock Information
  • Founded
  • ASMB 2005
  • LGO 1988
  • Country
  • ASMB United States
  • LGO Canada
  • Employees
  • ASMB N/A
  • LGO N/A
  • Industry
  • ASMB Biotechnology: Pharmaceutical Preparations
  • LGO
  • Sector
  • ASMB Health Care
  • LGO
  • Exchange
  • ASMB Nasdaq
  • LGO Nasdaq
  • Market Cap
  • ASMB 76.9M
  • LGO 91.0M
  • IPO Year
  • ASMB 2010
  • LGO 2007
  • Fundamental
  • Price
  • ASMB $15.40
  • LGO $1.28
  • Analyst Decision
  • ASMB Strong Buy
  • LGO Strong Buy
  • Analyst Count
  • ASMB 3
  • LGO 1
  • Target Price
  • ASMB $33.00
  • LGO $3.70
  • AVG Volume (30 Days)
  • ASMB 14.3K
  • LGO 91.8K
  • Earning Date
  • ASMB 05-08-2025
  • LGO 05-14-2025
  • Dividend Yield
  • ASMB N/A
  • LGO N/A
  • EPS Growth
  • ASMB N/A
  • LGO N/A
  • EPS
  • ASMB N/A
  • LGO N/A
  • Revenue
  • ASMB $32,154,000.00
  • LGO $110,968,000.00
  • Revenue This Year
  • ASMB $33.96
  • LGO $23.62
  • Revenue Next Year
  • ASMB N/A
  • LGO $41.27
  • P/E Ratio
  • ASMB N/A
  • LGO N/A
  • Revenue Growth
  • ASMB 148.33
  • LGO N/A
  • 52 Week Low
  • ASMB $7.75
  • LGO $1.12
  • 52 Week High
  • ASMB $19.93
  • LGO $2.84
  • Technical
  • Relative Strength Index (RSI)
  • ASMB 69.79
  • LGO 37.27
  • Support Level
  • ASMB $13.13
  • LGO $1.27
  • Resistance Level
  • ASMB $14.35
  • LGO $1.36
  • Average True Range (ATR)
  • ASMB 0.73
  • LGO 0.08
  • MACD
  • ASMB 0.10
  • LGO -0.00
  • Stochastic Oscillator
  • ASMB 84.79
  • LGO 23.75

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

About LGO Largo Inc.

Largo Inc is committed to the production and supply of high-quality vanadium products. The company is also focused on the advancement of renewable energy storage solutions through Largo Clean Energy and its vanadium redox flow battery technology. The Company is engaged in the mining, exploration, and development of mineral properties, predominantly in Brazil, through which it produces and supplies vanadium products VPURE Flake, VPURE+ Flake, and VPURE+ Powder. The company has operating segments: sales & trading, mine properties, which generates key revenue, corporate, exploration and evaluation properties, Clean Energy, and Largo Physical Vanadium.

Share on Social Networks: